5-[(4-bromophenyl)sulfonylamino]-N-(2-methoxyethyl)-2-piperazin-1-ylbenzamide;2,2,2-trifluoroacetic acid

C22H26BrF3N4O6S — CID 146062449

IUPAC5-[(4-bromophenyl)sulfonylamino]-N-(2-methoxyethyl)-2-piperazin-1-ylbenzamide;2,2,2-trifluoroacetic acid
SMILESCOCCNC(=O)c1cc(NS(=O)(=O)c2ccc(Br)cc2)ccc1N1CCNCC1.O=C(O)C(F)(F)F
InChIInChI=1S/C20H25BrN4O4S.C2HF3O2/c1-29-13-10-23-20(26)18-14-16(4-7-19(18)25-11-8-22-9-12-25)24-30(27,28)17-5-2-15(21)3-6-17;3-2(4,5)1(6)7/h2-7,14,22,24H,8-13H2,1H3,(H,23,26);(H,6,7)
InChIKeyQBZFSGDULKDNAV-UHFFFAOYSA-N
MW611.44 g/mol
LogP2.67
Rot. Bonds8

About 5-[(4-bromophenyl)sulfonylamino]-N-(2-methoxyethyl)-2-piperazin-1-ylbenzamide;2,2,2-trifluoroacetic acid

5-[(4-bromophenyl)sulfonylamino]-N-(2-methoxyethyl)-2-piperazin-1-ylbenzamide;2,2,2-trifluoroacetic acid (PubChem CID 146062449) has the molecular formula C22H26BrF3N4O6S and a molecular weight of 611.44 g/mol. Its IUPAC name is 5-[(4-bromophenyl)sulfonylamino]-N-(2-methoxyethyl)-2-piperazin-1-ylbenzamide;2,2,2-trifluoroacetic acid.

Molecular Properties

Compound Name5-[(4-bromophenyl)sulfonylamino]-N-(2-methoxyethyl)-2-piperazin-1-ylbenzamide;2,2,2-trifluoroacetic acid
PubChem CID146062449
Molecular FormulaC22H26BrF3N4O6S
Molecular Weight611.44 g/mol
Exact Mass610.07
IUPAC Name5-[(4-bromophenyl)sulfonylamino]-N-(2-methoxyethyl)-2-piperazin-1-ylbenzamide;2,2,2-trifluoroacetic acid
SMILESCOCCNC(=O)c1cc(NS(=O)(=O)c2ccc(Br)cc2)ccc1N1CCNCC1.O=C(O)C(F)(F)F
InChIInChI=1S/C20H25BrN4O4S.C2HF3O2/c1-29-13-10-23-20(26)18-14-16(4-7-19(18)25-11-8-22-9-12-25)24-30(27,28)17-5-2-15(21)3-6-17;3-2(4,5)1(6)7/h2-7,14,22,24H,8-13H2,1H3,(H,23,26);(H,6,7)
InChIKeyQBZFSGDULKDNAV-UHFFFAOYSA-N
XLogP2.67
TPSA137.07 Ų
H-Bond Donors4
H-Bond Acceptors7
Rotatable Bonds8
Heavy Atoms37
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500611.44
LogP ≤ 52.67
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_A(478)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 5-[(4-bromophenyl)sulfonylamino]-N-(2-methoxyethyl)-2-piperazin-1-ylbenzamide;2,2,2-trifluoroacetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-[(4-bromophenyl)sulfonylamino]-N-(2-methoxyethyl)-2-piperazin-1-ylbenzamide;2,2,2-trifluoroacetic acid?
The IUPAC name of 5-[(4-bromophenyl)sulfonylamino]-N-(2-methoxyethyl)-2-piperazin-1-ylbenzamide;2,2,2-trifluoroacetic acid (CID 146062449) is 5-[(4-bromophenyl)sulfonylamino]-N-(2-methoxyethyl)-2-piperazin-1-ylbenzamide;2,2,2-trifluoroacetic acid.
What is the SMILES notation for 5-[(4-bromophenyl)sulfonylamino]-N-(2-methoxyethyl)-2-piperazin-1-ylbenzamide;2,2,2-trifluoroacetic acid?
The canonical SMILES for 5-[(4-bromophenyl)sulfonylamino]-N-(2-methoxyethyl)-2-piperazin-1-ylbenzamide;2,2,2-trifluoroacetic acid is COCCNC(=O)c1cc(NS(=O)(=O)c2ccc(Br)cc2)ccc1N1CCNCC1.O=C(O)C(F)(F)F.
What is the InChIKey of 5-[(4-bromophenyl)sulfonylamino]-N-(2-methoxyethyl)-2-piperazin-1-ylbenzamide;2,2,2-trifluoroacetic acid?
The InChIKey is QBZFSGDULKDNAV-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H25BrN4O4S.C2HF3O2/c1-29-13-10-23-20(26)18-14-16(4-7-19(18)25-11-8-22-9-12-25)24-30(27,28)17-5-2-15(21)3-6-17;3-2(4,5)1(6)7/h2-7,14,22,24H,8-13H2,1H3,(H,23,26);(H,6,7).
What are the key properties of 5-[(4-bromophenyl)sulfonylamino]-N-(2-methoxyethyl)-2-piperazin-1-ylbenzamide;2,2,2-trifluoroacetic acid?
5-[(4-bromophenyl)sulfonylamino]-N-(2-methoxyethyl)-2-piperazin-1-ylbenzamide;2,2,2-trifluoroacetic acid has a molecular weight of 611.44 g/mol, XLogP of 2.67, 8 rotatable bonds, 4 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[(4-bromophenyl)sulfonylamino]-N-(2-methoxyethyl)-2-piperazin-1-ylbenzamide;2,2,2-trifluoroacetic acid is sourced from PubChem (CID 146062449), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).